BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 3097317)

  • 1. Antiinflammatory and aldose reductase inhibitory activity of some tricyclic arylacetic acids.
    Cerelli MJ; Curtis DL; Dunn JP; Nelson PH; Peak TM; Waterbury LD
    J Med Chem; 1986 Nov; 29(11):2347-51. PubMed ID: 3097317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and aldose reductase inhibitory activity of 7-sulfamoylxanthone-2-carboxylic acids.
    Pfister JR; Wymann WE; Mahoney JM; Waterbury LD
    J Med Chem; 1980 Nov; 23(11):1264-7. PubMed ID: 6779009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and in vitro aldose reductase inhibitory activity of compounds containing an N-acylglycine moiety.
    DeRuiter J; Swearingen BE; Wandrekar V; Mayfield CA
    J Med Chem; 1989 May; 32(5):1033-8. PubMed ID: 2496229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and aldose reductase inhibitory activity of substituted 2-oxoquinoline-1-acetic acid derivatives.
    DeRuiter J; Brubaker AN; Whitmer WL; Stein JL
    J Med Chem; 1986 Oct; 29(10):2024-8. PubMed ID: 3093680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of aldehyde reductase by aldose reductase inhibitors.
    Sato S; Kador PF
    Biochem Pharmacol; 1990 Sep; 40(5):1033-42. PubMed ID: 2117925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and rat lens aldose reductase inhibitory activity of some benzopyran-2-ones.
    Brubaker AN; DeRuiter J; Whitmer WL
    J Med Chem; 1986 Jun; 29(6):1094-9. PubMed ID: 3086557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isomeric benzoylpyrroleacetic acids: some structural aspects for aldose reductase inhibitory and anti-inflammatory activities.
    Demopoulos VJ; Rekka E
    J Pharm Sci; 1995 Jan; 84(1):79-82. PubMed ID: 7714750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Aldose reductase inhibitors].
    Dostert P; Strolin Benedetti M
    J Pharmacol; 1986; 17(4):483-96. PubMed ID: 3104688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of lens and cataract aldose reductase by protein-bound anti-rheumatic drugs: salicylate, indomethacin, oxyphenbutazone, sulindac.
    Sharma YR; Cotlier E
    Exp Eye Res; 1982 Jul; 35(1):21-7. PubMed ID: 6807700
    [No Abstract]   [Full Text] [Related]  

  • 10. Structure-activity studies of aldose reductase inhibitors containing the 4-oxo-4h-chromen ring system.
    Kador PF; Sharpless NE
    Biophys Chem; 1978 Mar; 8(1):81-5. PubMed ID: 417745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on lens-aldose-reductase inhibitor in medicinal plants. II. Active constituents of Monochasma savatierii Franch. et Maxim.
    Kohda H; Tanaka S; Yamaoka Y; Yahara S; Nohara T; Tanimoto T; Tanaka A
    Chem Pharm Bull (Tokyo); 1989 Nov; 37(11):3153-4. PubMed ID: 2517245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-activity correlation of flavonoids for inhibition of bovine lens aldose reductase.
    Iinuma M; Tanaka T; Mizuno M; Katsuzaki T; Ogawa H
    Chem Pharm Bull (Tokyo); 1989 Jul; 37(7):1813-5. PubMed ID: 2509087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Irreversible aldose reductase inhibitors.
    Kador PF; Gurley RC; Ares JJ; Miller DD
    Prog Clin Biol Res; 1987; 232():353-65. PubMed ID: 3112788
    [No Abstract]   [Full Text] [Related]  

  • 14. Inhibition of aldose reductase by flavonoids: possible attenuation of diabetic complications.
    Varma SD
    Prog Clin Biol Res; 1986; 213():343-58. PubMed ID: 3086893
    [No Abstract]   [Full Text] [Related]  

  • 15. Design and synthesis of 2-(arylamino)-4(3H)-quinazolinones as novel inhibitors of rat lens aldose reductase.
    DeRuiter J; Brubaker AN; Millen J; Riley TN
    J Med Chem; 1986 May; 29(5):627-9. PubMed ID: 3084783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of aldose reductases from rat and bovine lenses by flavonoids.
    Okuda J; Miwa I; Inagaki K; Horie T; Nakayama M
    Biochem Pharmacol; 1982 Dec; 31(23):3807-22. PubMed ID: 6818971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aldose reductase inhibition by anti-allergy drugs.
    Kador PF; Sharpless NE; Goosey JD
    Prog Clin Biol Res; 1982; 114():243-59. PubMed ID: 6131432
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmacophor requirements of the aldose reductase inhibitor site.
    Kador PF; Sharpless NE
    Mol Pharmacol; 1983 Nov; 24(3):521-31. PubMed ID: 6415401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and biological evaluation of irreversible inhibitors of aldose reductase.
    Ares JJ; Kador PF; Miller DD
    J Med Chem; 1986 Nov; 29(11):2384-9. PubMed ID: 3097318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and aldose reductase-inhibitory activities of structural analogues of WF-3681, a novel aldose reductase inhibitor.
    Namiki T; Baba Y; Suzuki Y; Nishikawa M; Sawada K; Itoh Y; Oku T; Kitaura Y; Hashimoto M
    Chem Pharm Bull (Tokyo); 1988 Apr; 36(4):1404-14. PubMed ID: 3138031
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.